Operates Loblaw Companies Limited, a major grocery and pharmacy retailer in Canada. Now — the numbers.
This is an established company with proven profits.
No real growth (5% a year).
The gap is $13.0B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 33× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It pays out $0.88 per share each year — regular cash for whoever holds the stock.
The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn.
Costs swallow the gains that sales growth brings in.
Against everything we grade, WNGRF lands near the bottom. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: WNGRF does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: the revenue breakdown.